Recce Pharmaceuticals Ltd
ASX:RCE

Watchlist Manager
Recce Pharmaceuticals Ltd Logo
Recce Pharmaceuticals Ltd
ASX:RCE
Watchlist
Price: 0.58 AUD 4.5% Market Closed
Market Cap: 167.7m AUD

Wall Street
Price Targets

RCE Price Targets Summary
Recce Pharmaceuticals Ltd

There are no price targets for RCE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Recce Pharmaceuticals Ltd Competitors:
Price Targets
CIPLA
Cipla Ltd
13% Upside
EAH
ECO Animal Health Group PLC
88% Upside
GLENMARK
Glenmark Pharmaceuticals Ltd
11% Upside
600195
China Animal Husbandry Industry Co Ltd
5% Upside
IPN
Ipsen SA
9% Upside
1093
CSPC Pharmaceutical Group Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Recce Pharmaceuticals Ltd

The compound annual growth rate of Recce Pharmaceuticals Ltd's revenue for the next 3 years is 18%.

N/A
Past Growth
18%
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Recce Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Recce Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCE's stock price target?
Not Available

RCE doesn't have any price targets made by Wall Street professionals.

What is Recce Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
18%

The compound annual growth rate of Recce Pharmaceuticals Ltd's revenue for the next 3 years is 18%.

Back to Top